Walleye Trading Advisors »

Kalaris Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $95k 11k 8.44

More positions owned by Walleye Trading Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Microsoft Corporation (MSFT)
Boston Scientific Corporation (BSX)
Spdr Gold Tr Gold Shs (GLD)
Bank of America Corporation (BAC)
Tesla Motors (TSLA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Ford Mtr Note 3/1 (Principal)
Intuitive Surgical Com New (ISRG)

View all positions for Walleye Trading Advisors

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Siren
Alyeska Investment Group
Ikarian Capital
Vanguard Group
Woodline Partners
ADAR1 Capital Management
Boothbay Fund Management
Raymond James Financial
Renaissance Technologies
Redmile Group
Geode Capital Management
683 Capital Management

View all funds holding Kalaris Therapeutics